Skip to main content

Advertisement

SpringerLink
Log in

Systemic lupus erythematosus — disease management

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Austin HA, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614

    Google Scholar 

  2. Austin HA III, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45:544

    Google Scholar 

  3. Balletta M, Sabella D, Magri P, Sepe V, Stanziale P, Di Luccio R, Colucci G, Fuiano G (1992) Ciclosporin plus steroids versus steroids alone in the treatment of lupus nephritis. Contrib Nephrol 99:129

    Google Scholar 

  4. Balow JE, Austin HA, Muenz LR, Joyce KM, Antonovych TT, Klippel JH, Steinberg AD, Plotz PH, Decker JL (1984) Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 311:491

    Google Scholar 

  5. Barile L, Lavalle C (1992) Transverse myelitis in systemic lupus erythematosus — the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 10:370

    Google Scholar 

  6. Berger CL, Perez M, Laroche L, Edelson R (1990) Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol 94:52

    Google Scholar 

  7. Bernstein HN (1983) Ophthalmalogic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med 75:25

    Google Scholar 

  8. Boumpas DT, Barez S, Klippel JH, Balow JE (1990) Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 112:674

    Google Scholar 

  9. Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE (1991) Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 81:975

    Google Scholar 

  10. Boumpas DT, Austin Liii Vaughan EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE (1992) Controlled trial of pulse methylprednisolone versus two reimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741

    Article  CAS  PubMed  Google Scholar 

  11. Boumpas DT, Austin HA III, Vaughan EM, Yarboro CH, Klippel JH, Balow JE (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366

    Google Scholar 

  12. Branch DW, Scott JR, Kochenour NK, Hershgold E (1985) obstetric complications associated with the lupus anticoagulant. N Engl J Med 313:1322

    Google Scholar 

  13. Budman D and Steinberg AD (1976) Relationship between hypertension and renal disease in systemic lupus erythematosus. Arch Intern Med 136:1003

    Google Scholar 

  14. Callen JP (1990) Treatment of cutaneous lesions in patients with lupus erythematosus. Dermatol Clin 8:355

    Google Scholar 

  15. Carette S, Klippel JH, Decker JL, Austin III HA, Plotz PH, Steinberg AD, Balow JE (1983) Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. Ann Intern Med 99:1

    Google Scholar 

  16. Clark WF, Dau PC, Euler HH, Guillevin L, Hasford J, Heer AH, Jones JV, Kashgarian M, Knatterud G, Lockwood CM (1991) Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG). J Clin Apheresis 6:40

    Google Scholar 

  17. Cohen MG, Lui SF (1992) Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy. J Rheumatol 19:803

    Google Scholar 

  18. Coon WW (1988) Splenectomy for cytopenias associated with systemic lupus erythematosus. Am J Surg 155:391

    Google Scholar 

  19. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166:1318

    Google Scholar 

  20. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164

    Google Scholar 

  21. Derksen RH, Bouma BN, Kater L (1986) The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosus. Scand J Rheumatol 15:179

    Google Scholar 

  22. Donadio JV Jr, Holley KE, Ferguson RH, Ilstrup DM (1978) Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299:1151

    Google Scholar 

  23. Druzin ML, Lockshin M, Edersheim TG, Hutson JM, Krauss AL, Kogut E (1987) Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am J Obstet Gynecol 157:1503

    Google Scholar 

  24. Ermak TH, Steger HJ, Wofsy D (1989) Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node. Lab Invest 61:447

    Google Scholar 

  25. Favre H, Miescher PA, Huang YP, Chatelanat F, Mihatsch MJ (1989) Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 9 [Suppl 1]:57

    Google Scholar 

  26. Feutren G, Querin S, Tron F, Noel LH, Chatenoud L, Lesavre P, Bach JF (1986) The effects of cyclosporine in patients with systemic lupus. Transplant Proc 18:643

    Google Scholar 

  27. Gourley MF, Seldin MF, Steinberg AD (1992) Immunoregulatory agents. In: Gallin JI, Goldstein IM, Synderman R (eds) Inflammation: basic principles and clinical correlates. Raven Press, New York, pp 1103–1126

    Google Scholar 

  28. Gruenberg JC, Van Slyck EJ, Abraham JP (1986) Splenectomy in systemic lupus erythematosus. Am Surg 52:366

    Google Scholar 

  29. Hahn BH (1993) Management of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Saunders, Philadelphia, pp 1043–1056

    Google Scholar 

  30. Hall S, McCormick JL, Greipp PR, Michel CJ, McKenna CH (1985) Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. Ann Intern Med 102:325

    Google Scholar 

  31. Hiepe F, Volk HD, Apostoloff E, von Baehr R, Emmrich F (1991) Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Lancet 338:1529

    Google Scholar 

  32. Hiepe F, Thiele B, Brink I, Volk HD, Emmrich F (1993) Investigations on the treatment of systemic lupus (SLE) with the monoclonal anti-CD4 antibody MAX.16H5. Arthritis Rheum 36:S227

    Google Scholar 

  33. Hirashima K, Yoshida Y, Asano S, Takaku F, Omine M, Furusawa S, Abe T, Dohy H, Tajiri M (1991) Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia. Biotherapy 3:297

    Google Scholar 

  34. Jacobs P, Wood L (1989) The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia. An interim analysis. Blut 59:92

    Google Scholar 

  35. Jacobs P, Wood L, Dent DM (1986) Results of treatment in immune thrombocytopenia. Q J Med 58:153

    Google Scholar 

  36. Janson CH (1993) Biology of monoclonal antibodies in tumor therapy. Med Oncol Tumor Pharmacother 10:21

    Google Scholar 

  37. Kaaja R, Julkunen H, Ammala P, Palosuo T, Kurki P (1993) Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 72:63

    Google Scholar 

  38. Kater L, Derksen RH, Heneë RJ (1991) Treatment of systemic lupus erythematosus: which options do we have for therapy regimens? Rheumatol Int 11:137

    Google Scholar 

  39. Klippel JH (1993) Is aggressive therapy effective for lupus? Rheum Dis Clin North Am 19:249

    Google Scholar 

  40. Knobler RM, Graninger W, Lindmaier A, Trautinger F, Smolen JS (1992) Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum 35:319

    Google Scholar 

  41. Konradsen HB, Henrichsen J (1991) Pneumococcal infections in splenectomized children are preventable. Acta Paediatr Scand 80:423

    Google Scholar 

  42. Lahita RG, Cheng CY, Monder C, Bardin CW (1992) Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J Rheumatol 19:547

    Google Scholar 

  43. Lehman TJA (1991) Long-term outcome of systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 17:921

    Google Scholar 

  44. Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G (1991) Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatal 8:174

    Google Scholar 

  45. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 326:1373

    CAS  PubMed  Google Scholar 

  46. Lockshin MD (1993) Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 19:235

    Google Scholar 

  47. Lockshin MD, Qamar T, Druzin ML, Goei S (1987) Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol 14:259

    Google Scholar 

  48. Lockshin MD, Druzin ML, Qamar T (1989) Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 160:439

    Google Scholar 

  49. Lubbe WF, Butler WS, Palmer SJ, Liggins GC (1983) Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet I:1361

    Google Scholar 

  50. Mackenzie AH (1983) Dose refinements in long-term antimalarial therapy. Am J Med 75:40

    Google Scholar 

  51. McCune WJ, Friedman AW (1993) Immunosuppressive drug therapy for rheumatic desease. Curr Opin Rheumatol 5:282

    Google Scholar 

  52. McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox DA (1988) Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 318:1423

    Google Scholar 

  53. McInnes PM, Schuttinga JA, Sanslone WR, Stark SP, Klippel JH (1993) The economic impact of treatment of severe lupus nephritis with prednisone plus intravenous cyclophosphamide. Arthritis Rheum 36:S65

    Google Scholar 

  54. McLaughlin J, Gladman DD, Urowitz MB, Farewell VT, Cole E (1991) Kidney biopsy in systemic lupus erythematosus. II. Survival analysis according to biopsy results. Arthritis Rheum 24:1268

    Google Scholar 

  55. Nived O, Johansen PB, Sturfelt G (1993) Standardized ultraviolet-A exposure provokes skin reaction in systemic lupus erythematosus. Lupus 2:247

    Google Scholar 

  56. Norris DA, Weston WL, Sams WM (1977) The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro. J Lab Clin Med 90:569

    Google Scholar 

  57. Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ (1990) Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum 33:970

    Google Scholar 

  58. Panayi GS, Neille WA, Duthie JJR, McCormick JN (1973) Action of chloroquine phosphate in rheumatoid arthritis. I. Immunosuppressive effect. Ann Rheum Dis 32:316

    Google Scholar 

  59. Rihner M, McGrath H Jr (1992) Fluorescent light photosensitivity in patients with systemic lupus erythematosus. Arthritis Rheum 35:949

    Google Scholar 

  60. Rosove MH, Brewer PM (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303

    Google Scholar 

  61. Rosove MH, Tabsh K, Wasserstrum N, Howard P, Hahn BH, Kalunian KC (1990) Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 75:630

    Google Scholar 

  62. Ruzicka T, Sommerburg C, Goerz G, Kind P, Mensing H (1992) Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol 127:513

    Google Scholar 

  63. Salmeron G, Lipsky PE (1983) The immunosuppressive potential of antimalarials. Am J Med 75:19

    Google Scholar 

  64. Scala G, Oppenheim JJ (1983) Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1. J Immunol 131:1160

    Google Scholar 

  65. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ (1992) Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int 42:743

    Google Scholar 

  66. Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB (1992) The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 19:47

    Google Scholar 

  67. Sontheimer RD (1988) Lupus erythematosus. In: Provost TT, Farmer ER (eds) Current therapy in dermatology, vol. 2. Decker, Philadelphia, pp 123–128

    Google Scholar 

  68. Sontheimer RD (1993) Fluorescent light photosensitivity in patients with systemic lupus erythematosus. Arthritis Rheum 36:428

    Google Scholar 

  69. Stadler R, Ruszczak Z (1993) Interferons. New additions and indications for use. Dermatol Clin 11:187

    Google Scholar 

  70. Stafford FJ, Fleisher TA, Brown M, Lee G, Austin HA III, Balow JE, Klippel JH (1993) Clinical and biological effects of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus (SLE). Arthritis Rheum 36:S227

    Google Scholar 

  71. Steinberg AD (1986) The treatment of lupus nephritis. Kidney Int 30:769

    Google Scholar 

  72. Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945

    Google Scholar 

  73. Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boeger WA, Smathers PA, Taurog JD, Weinlein L, Duvic M (1979) Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 22:1170

    Google Scholar 

  74. Suzuki K, Hara M, Harigai M, Ishizuka T, Hirose T, Matsuki Y, Kawaguchi Y, Kitani A, Kawagoe M, amd Makamura H (1991) Continuous removal of anti-DNA antibody, using a new extracorporeal immunadsorption system, in patients with systemic lupus erythematosus. Arthritis Rheum 34:1546

    Google Scholar 

  75. The Canadian Hydroxychloroquine Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324:150

    Google Scholar 

  76. Theofilopoulos AN and Dixon FJ (1985) Murine models of systemic lupus erythematosus. Adv Immunol 37:269

    Google Scholar 

  77. Tolaymat A, Leventhal B, Sakarcan A, Kashima H, Monteiro C (1992) Systemic lupus erythematosus in a child receiving long-term interferon therapy. J Pediatr 120:429

    Google Scholar 

  78. Reference deleted

  79. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL (1993) Effects of oral adminstration of type II collagen on rheumatoid arthritis. Science 271:1727

    Google Scholar 

  80. Urowitz MB (1992) Is “aggressive” therapy necessary for systemic lupus erythemathosus? Rheum Dis Clin North Am 19:263

    Google Scholar 

  81. van Hollenhoven RF, Engleman EG, Elaine Lambert R, Lynda Lee YS, McGuire JL (1993) Treatment of systemic lupus erythematosus with dehydroepiandrosterone. Interim analysis of a double-blinded, randomized, placebo-controlled, clinical trial. Arthritis Rheum 36:S92

    Google Scholar 

  82. Vowel BR, Cassin M, Boufal MH, Walsh LJ, Rook AH (1992) Extracorporal photochemotherapy induces the production of tumor necrosis factor-α: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 98:686

    Google Scholar 

  83. Wacholtz MC, Lipsky PE (1992) Treatment of lupus nephritis with CD5 PLUS, and immunoconjugate of an anti-CD5 monoclonal antibody and ricin A chain. Arthritis Rheum 35:837

    Google Scholar 

  84. Waldmann TA (1991) Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity and immunodeficiency. Clin Immunol Immunopathol 61:S37

    Google Scholar 

  85. Wallace DJ, Metzger AL, Stecher VJ, Trunbull BA, Kern PA (1990) Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 32289:322

    Google Scholar 

  86. Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, Seeber S, Niederle N (1992) Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol 64:70

    Google Scholar 

  87. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321

    Google Scholar 

  88. West SG, Johnson SC (1988) Danazol for the treatment of refractroy autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern 108:703

    Google Scholar 

  89. Wofsy D (1993) Treatment of murine lupus with anti-CD4 monoclonal antibodies. Immunol Ser 59:221

    Google Scholar 

  90. Yarboro CH, Pacino F, Wesley R, Klippel JH, Amantea M (1993) Antiemetic efficacy of oral dexamethasome (DMT) and ondansetron (OND) in lupus nephritis (LN) patients. Arthritis Rheum 36:S228

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institutes of Arthritis and Musculoskeletal and Skin Diseases, Building 10, Room 9S210, 20982, Bethesda, MD, USA

    Mark F. Gourley

Authors
  1. Mark F. Gourley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gourley, M.F. Systemic lupus erythematosus — disease management. Springer Semin Immunopathol 16, 281–294 (1994). https://doi.org/10.1007/BF00197522

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00197522

Keywords

Search

Navigation